Diclofenac vs. Ropivacaine for Cesarean Section

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

A prospective, randomized, double blind study designed to investigate analgesic efficacy of wound infusion using diclofenac or ropivacaine following Cesarean section performed via a Pfannenstiel incision.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Meir Medical Center
• Treatments: Diclofenac; Ropivacaine

Criteria

Inclusion Criteria:

• Patients undergoing Cesarean section

Exclusion Criteria:

A history of clinically significant disease:

• cardiovascular

• pulmonary

• hepatic

• renal

• neurologic

• psychiatric

• metabolic disease